Clinical Trial Update: Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Aza-SAHA-GBM with autologous stem cell transplant for refractory lymphoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancers
• Lymphoma

Drugs mentioned

• Aza-SAHA-GBM

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-27